Quantcast
Last updated on April 18, 2014 at 8:33 EDT

Latest Bile acid malabsorption Stories

2013-05-20 08:27:11

NEW YORK, May 20, 2013 /PRNewswire/ -- Intercept Pharmaceuticals, Inc. ("Intercept", NASDAQ: ICPT), a clinical stage biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat chronic liver diseases, today announced positive initial results from OBADIAH, an ongoing Phase 2a trial of obeticholic acid (OCA) as a treatment for primary bile acid diarrhea (PBAD) presented at the Digestive Diseases Week conference. The initial results from...

2012-11-08 04:22:50

GOTHENBURG, Sweden, November 8, 2012 /PRNewswire/ -- Albireo AB (Gothenburg, Sweden; "Albireo"), a biopharmaceutical company specializing in gastroenterology, today announced that A4250 (an inhibitor of the ileal bile acid transporter, IBAT/ASBT) has been granted orphan-drug designation by the U.S Food and Drug Administration ("FDA") for the treatment of - Progressive Familial Intrahepatic Cholestasis (PFIC) - Primary Biliary Cirrhosis (PBC)...